Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
6.53
-0.11 (-1.66%)
Nov 5, 2024, 1:24 PM EST - Market open
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RXRX stock have an average target of 9.40, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 43.95% from the current stock price of 6.53.
Analyst Consensus: Buy
* Price targets were last updated on Sep 4, 2024.
Analyst Ratings
The average analyst rating for RXRX stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 2 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 4 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $16 → $11 | Strong Buy | Maintains | $16 → $11 | +68.45% | Sep 4, 2024 |
| Jefferies | Jefferies | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | -8.12% | Sep 3, 2024 |
| Leerink Partners | Leerink Partners | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +22.51% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +145.02% | Aug 9, 2024 |
| Keybanc | Keybanc | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +83.77% | Jul 11, 2024 |
Financial Forecast
Revenue This Year
70.38M
from 44.58M
Increased by 57.90%
Revenue Next Year
95.18M
from 70.38M
Increased by 35.23%
EPS This Year
-1.65
from -1.58
EPS Next Year
-1.82
from -1.65
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 92.7M | 267.7M | 218.4M |
| Avg | 70.4M | 95.2M | 128.4M |
| Low | 43.7M | 45.2M | 73.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 108.0% | 280.3% | 129.5% |
| Avg | 57.9% | 35.2% | 34.9% |
| Low | -1.9% | -35.8% | -22.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.53 | -1.32 | -1.12 |
| Avg | -1.65 | -1.82 | -1.47 |
| Low | -1.96 | -3.14 | -1.79 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.